Although it is unclear which cellular factor(s) is responsible for the genetic instability associated with initiating and sustaining cell transformation, it is known that many cancers have mutations that inactivate the Rb-mediated proliferation pathway. We show here that pRb inactivation and the resultant deregulation of one E2F family member, E2F1, leads to DNA double-strand break (DSB) accumulation in normal diploid human cells. These DSBs occur independent of Atm, p53, caspases, reactive oxygen species, and apoptosis. Moreover, E2F1 does not contribute to c-Myc-associated DSBs, indicating that the DSBs associated with these oncoproteins arise through distinct pathways. We also find E2F1-associated DSBs in an Rb mutated cancer cell line in the absence of an exogenous DSB stimulus. These basal, E2F1-associated DSBs are not observed in a p16 ink4a inactivated cancer cell line that retains functional pRb, unless pRb is depleted. Thus, Rb status is key to regulating both the proliferation promoting functions associated with E2F and for preventing DNA damage accumulation if E2F1 becomes deregulated. Taken together, these data suggest that loss of Rb creates strong selective pressure, via DSB accumulation, for inactivating p53 mutations and that E2F1 contributes to the genetic instability associated with transformation and tumorigenesis.
Introduction
Inactivation of growth control pathways is essential for cancer formation, which is thought to explain why most cancer cells inactivate the retinoblastoma tumor suppressor (pRb) (Nevins, 2001 ). When pRb is inactivated, the genes involved in DNA replication and S-phase progression are derepressed and cells enter the cell cycle (Morgenbesser et al., 1994) . Although pRb belongs to a family of proteins, mutations affecting p107 and p130
have not yet been identified in human cancers.
The mechanism of pRb inactivation varies between tumors and includes mutation or deletion of the Rb locus, overexpression and activation of pRb regulating oncogenes, cdk inhibitors loss, and inactivation and/or degradation of pRb by viral oncoproteins from small DNA tumor viruses (Nevins, 2001) . Inactivating RB releases the E2F transcription factors. The activator class of E2F proteins, namely E2F1, E2F2, and E2F3a, all potently stimulate quiescent rodent cells to enter S phase when ectopically expressed (Johnson et al., 1993; Kowalik et al., 1995; DeGregori et al., 1997) and are specifically repressed by the pRb member of the RB family (Dyson, 1998; Nevins, 2001) .
Expressing the E7 protein of the human papillomavirus (HPV) inactivates the RB family of proteins and induces genomic instability in diploid human fibroblasts (White et al., 1994) . More recently, this genomic instability has been defined to include abnormal mitotic figures, such as centrosome and centriole duplications and anaphase bridges, which may result from DNA breaks and/or lagging chromosome material (Duensing and Munger, 2002) . However, the extent to which pRb inactivation contributes to genomic changes is not yet fully understood.
Expressing E7 in normal human cells activates proteins that respond to genomic stress (Tominaga et al., 1999; Berkovich and Ginsberg, 2003; Rogoff et al., 2004) . Two of these proteins, Atm and Chk2, are kinases activated in response to numerous cell stressors, although their role in DNA double-strand break (DSB) signaling is best characterized (Sancar et al., 2004) . Interestingly, activation of Atm and Chk2 by E7, as well as p53-dependent apoptosis, is dependent on E2F1 but not the other activator E2F proteins (Rogoff et al., 2004) . These observations highlight a conundrum: expression of all three activator E2Fs potently induces S-phase progression; however, only E2F1 expression efficiently induces p53-dependent apoptosis. Therefore, deregulated E2F1 must generate an additional signal to stimulate cells to undergo apoptosis.
Given that E2F1 is necessary for E7-induced kinase activation and that pRb, the negative regulator of E2F1, is inactivated in most human tumors, we asked whether pRb inactivation and the resulting E2F1 deregulation leads to DSB accumulation in human cells. Indeed, we found that specifically depleting pRb using RNAi, or inactivating RB family members by expressing E7, resulted in DSB accumulation in normal human cells. These DSBs were attributed to the deregulation of E2F1 and not the other activator E2F proteins. Cells treated with caspase inhibitors or lacking functional Atm or p53 accumulated E2F1-mediated DSBs in the absence of apoptosis. We also found that E2F1 was not required for c-Myc-associated DSB accumulation, and unlike the DSBs associated with c-Myc expression, E2F1-associated DSBs were not a result of generating reactive oxygen species (ROS), indicating that the DSBs associated with each oncoprotein arise through distinct pathways. Furthermore, we provide evidence that an Rb inactivated cancer cell line, SaOS2, has E2F1-associated DSBs in the absence of an exogenous DSB stimulus. However, these basal, E2F1-dependent DSBs were not observed in the p16 ink4a inactivated cancer cell line, U2OS, unless pRb is inactivated. Thus, Rb status is key to regulating both the proliferation-promoting functions associated with E2F and for preventing DNA damage accumulation if E2F1 becomes deregulated. Taken together, these data suggest that Rb loss creates strong selective pressure, via DSB accumulation, for compensatory p53 mutations and that E2F1 contributes to the genetic instability associated with transformation and tumorigenesis.
Results
Inactivating pRb results in DNA damage recognition foci and DSB accumulation Previously, we showed that deregulation of E2F1 activates Atm and Chk2, both of which also respond to DSB accumulation (Rogoff et al., 2004) . Given that pRb regulates E2F1, we asked whether the cell's response to pRb inactivation mimics the DSB response. Normal human fibroblasts (NHFs) transfected with siRNAs designed to deplete pRb (siRb) were immunostained for localization of the phosphorylated form of the H2AX histone protein (gH2AX) into discrete foci. In response to DSBs, H2AX is phosphorylated and localizes adjacent to the sites of the breaks (Rogakou et al., 1998; Paull et al., 2000) . Two siRNAs effectively decreased pRb levels ( Figure 1a ) and subsequently resulted in apoptosis (data not shown). When gH2AX localization was examined, siRb-transfected NHFs localized gH2AX into foci in approximately 33% of the cells, compared to about 7% of siCon-transfected cells (Figure 1b and c) . These results suggest that pRb loss may generate a signal similar to that produced in response to DSBs.
To determine whether pRb inactivation leads to DSB accumulation, we performed neutral comet assays, which specifically detect DSBs (Olive et al., 1991) . We found an approximate fivefold increase in the percentage of siRb-transfected cells positive for DSB accumulation compared to siCon-transfected cells (Figure 1d ), suggesting that DSBs accumulate in cells that have pRb inactivated.
HPV E7 expression results in gH2AX foci formation and DSB accumulation To determine whether E7 expression also leads to DSB accumulation, NHFs infected with recombinant adenovirus encoding E7 (AdE7) were immunostained for gH2AX foci localization. Approximately 65% of E7-expressing NHFs localized gH2AX into foci compared to less than 5% in control-infected cells (Figure 2a and b). When DSB accumulation was examined by neutral comet assay, we found an approximate 4-5-fold increase in the percentage of E7-expressing cells with DSBs as compared to control cells (32.1 and 7.8%, respectively) (Figure 2c and d) . These results show that DSBs accumulate in cells when RB is inactivated by E7 expression.
DSB accumulation and gH2AX foci formation requires E2F1
Given that Atm and Chk2 activation by E7 is E2F1 dependent (Rogoff et al., 2004) , we transfected NHFs with siRNAs designed to deplete E2F1 (siE2F1; Figure 3a ) and found that two of three siRNAs effectively depleted E2F1 levels. Transfected cells were subsequently infected with AdE7 and immunostained for gH2AX foci localization. Transfection of E7-expressing cells with siE2F1 substantially decreased (80.7 vs 26.4%) the percentage of cells positive for gH2AX foci formation compared to transfection with siCon ( Figure 3b ). To determine whether foci formation was restricted to E2F1, we transfected siRNAs designed to deplete E2F3a. E7-expressing cells that were transfected with siRNAs directed against E2F3a showed virtually no effect on gH2AX foci formation, despite efficiently reducing E2F3a levels ( Figure 3) .
To further investigate whether the induction of DSB accumulation in NHFs was specific to deregulated E2F1 protein, we overexpressed E2F1 and E2F3a with recombinant adenoviruses (AdE2F1 and AdE2F3a, respectively) and immunostained for gH2AX foci or performed neutral comet assays. Cells overexpressing E2F1 induced gH2AX foci formation to levels similar to those observed for cells expressing E7 (Figure 4a ). These results sharply contrast the results of cells transduced with AdE2F3a, which were unable to induce gH2AX foci formation even when the multiplicity of infection (MOI) of AdE2F3a was increased two-or threefold. In addition, E2F1-expressing cells accumulated DSBs by neutral comet assay to levels similar to those observed for cells expressing E7 or transfected with siRb ( Figure 4b ), whereas expression of E2F3a (Figure 4b ) or E2F2 (data not shown) did not cause DSBs to accumulate. These results highlight the unique property of deregulated E2F1 among the activator E2F proteins to accumulate DSBs. DSB accumulation and gH2AX foci formation occur independent of Atm, p53, caspases, and reactive oxygen species To ensure that the DSB accumulation in response to deregulated E2F1 was not due to activation of the apoptotic program, we measured DSB accumulation in cells that were not undergoing apoptosis. E2F1-and E7-induced apoptosis are compromised in fibroblasts from ataxia telangiectasia (AT) patients, which lack functional Atm (Powers et al., 2004; Rogoff et al., 2004) . We found that AT cells expressing either E2F1 or E7 localized gH2AX foci similar to normal dermal fibroblasts (NDFs) albeit to slightly lower levels ( Figure 5a ).
Similarly, DSB accumulation as determined by neutral comet assay also occurred ( Figure 5b ).
NHFs were transfected with siRNAs designed to deplete p53 (sip53; Figure 5c ) and then infected with either AdE2F1 or AdE7 to determine whether gH2AX foci and DSBs accumulate when p53 is depleted. Regardless of p53 levels, cells expressing either E2F1 or E7 localized gH2AX to discrete foci and accumulated DSBs (Figure 5d and e). However, E2F1-induced apoptosis was severely compromised when p53 was depleted ( Figure 5c ).
We next tested whether gH2AX foci form when E2F1 is deregulated and caspase activity is inhibited to determine whether DSBs accumulate in the absence of caspase activity. We found that although zVAD-fmk, a broad-spectrum caspase inhibitor, could prevent caspase-3 cleavage, it did not affect the percentage of cells positive for gH2AX foci when pRb was depleted (Figure 5f ).
Additionally, examination of foci formation and neutral comet assays were performed 24 hpi and appreciable E2F1-or E7-induced apoptosis levels were not observed until 72-96 hpi (Frame et al., submitted; Rogoff et al., 2004) . Together, the data from the AT fibroblasts, sip53 transfection, and caspase inhibitor experiments, as well as the time table for apoptosis induction, indicate that E2F1-induced DSB accumulation is not the result of activating the apoptotic program.
It has been suggested that E2F1 expression induces ROS (Tanaka et al., 2002) , although others have challenged this conclusion (Powers et al., 2004) . ROS generation could provide a potential mechanism for E2F1-induced DSB accumulation. We treated NHFs expressing E2F1 or E7 with N-acetylcysteine (NAC), a ROS inhibitor, and found that NAC had no effect on the percentage of cells positive for gH2AX foci when E2F1 or E7 was expressed (Figure 6a ).
E2F1 is not required for c-Myc-associated DSB accumulation
Because c-Myc expression can induce DSBs through ROS formation (Biroccio et al., 2001; Tanaka et al., 2002; Vafa et al., 2002) , AdMyc-infected cells were treated with NAC and monitored for gH2AX foci formation. Although NAC did not change the percentage of cells positive for gH2AX foci when c-Myc was overexpressed, an approximate 50% reduction in the number of foci per cell was observed (Figure 6b and c), consistent with an earlier study (Vafa et al., 2002) . Because it was suggested that E2F1 is required for c-Myc-mediated apoptosis (Leone et al., 2001) , we next determined if E2F1 contributes to gH2AX foci formation in c-Myc-overexpressing cells. We found that siE2F1 did not decrease the percentage of cells positive for gH2AX foci formation nor the number of foci per cell when c-Myc was overexpressed (Figure 6b and d) . Furthermore, siE2F1 and NAC treatment together did not reduce the number of gH2AX foci induced by c-Myc overexpression beyond the effect of NAC alone. As expected, siE2F1 reduced the percentage of cells positive for gH2AX foci formation when E7 was expressed, and NAC treatment in conjunction with siE2F1 had no additional effect on the percentage of cells positive for gH2AX foci or the number of foci per cell (Figure 6b and c). Lastly, transfection with siRNAs directed against E2F3a did not affect c-Myc-or E7-induced gH2AX foci formation. Taken together, these results show that ROS generation is not responsible for the DSB accumulation associated with pRb inactivation or E2F1 overexpression. In addition, E2F1 does not appear to contribute to DSB accumulation associated with c-Myc overexpression.
Endogenous E2F1 contributes to DSB accumulation in cancer cell lines when Rb is inactivated Because we found that deregulated E2F1 results in DSB accumulation in normal cells, we speculated that cancer cells with Rb mutations might have DSBs. The osteosarcoma cell line, SaOS2, which has Rb inactivated, was examined for basal levels of DSBs and 
compared to U2OS cells, which have p16
INK4a inactivated, but otherwise retain functional pRb. We immunostained both cell lines for endogenous gH2AX foci and found that SaOS2, but not U2OS, cells stained strongly for gH2AX foci (Figure 7a ). When SaOS2 cells were transfected with siE2F1, the percentage of gH2AX-positive cells was reduced about 50% (Figure 7a-c) . Given that Rb is wild type in U2OS cells, we speculated that inactivating Rb in these cells might increase the basal levels of gH2AX foci. Transfection of U2OS cells with siRbA resulted in an approximate sixfold increase in the percentage of cells with basal gH2AX foci (Figure 7d ). These DSB-associated foci were also observed when E7 was expressed in U2OS cells and were sensitive to siE2F1 transfection, but not siRNAs directed against E2F3a. Therefore, Rb inactivation and the resultant E2F1 deregulation increase the occurrence of DSBs in cancer cell lines and raise the possibility that this process provides opportunities for additional mutations.
Discussion

Inactivation of Rb and deregulation of E2F1
The consequences of Rb loss to tumorigenesis have largely been attributed to derepression of cell cycle progression. However, we show that another consequence of Rb inactivation is the accumulation of DSBs due to deregulated E2F1. These, like other DSBs, may manifest as genomic rearrangements, chromosomal abnormalities, DNA repair errors, and aneuploidy. Indeed, recent data suggest that loss of DNA damage checkpoint control encourages the progression of cancer through different stages of tumorigenesis (Bartkova et al., 2005; Gorgoulis et al., 2005) . We now offer evidence that the deregulation of E2F1 upon pRb inactivation contributes to the DSB accumulation observed in diploid and tumor cells.
Previous work has shown that E7 expression in keratinocytes leads to DNA breaks as assessed by alkaline comet assay (Duensing and Munger, 2002) , which detects both single-and double-stranded breaks (Olive et al., 1991) . We concluded that these breaks are DSBs based on the results of neutral comet assays (Figure 2c and d) and the formation of gH2AX foci (Figure 3) . Because siE2F1 was able to inhibit E7-associated DSB accumulation (Figure 3 ) and siRb transfection led to DSB accumulation (Figure 1) , the DSBs are attributed to the inactivation of pRb rather than to other E7 activities. These results raise the possibility that the genomic instability associated with E7 expression is due to the DSBs that are generated when pRb is inactivated. Nuclear oncoproteins, DSB accumulation, and apoptosis Many tumors have deregulated c-Myc expression, perhaps due to its growth-and proliferation-promoting activities, and the relationship between c-Myc and E2F1 is complex (Matsumura et al., 2003) . Our finding that E2F1 is not required for c-Myc-associated DSBs implies that c-Myc-and E2F1-associated DSBs are generated through distinct pathways. Why there is a disconnect for E2F1 dependency in c-Myc-mediated apoptosis and not for c-Myc-associated DSB accumulation is unclear beyond the studies being performed in different species.
The question remains as to how deregulated E2F1 results in DSBs. One possibility is that deregulated E2F1 may prevent the timely repair of DSBs that arise endogenously, thereby allowing these breaks to persist. In support of this idea, the number of gH2AX foci, and presumably DSBs, is relatively low in E7-or E2F1-expressing cells (Figure 6 ), which may explain why it was not detected in AdE2F1-infected NHFs by immunoblotting (Powers et al., 2004) . Alternatively, deregulated E2F1 may destabilize replication forks, causing them to stall and collapse, perhaps a result of imbalances in the expression of E2F1 target gene products involved in dNTP synthesis or DNA replication. However, replication fork collapse is usually signaled by the Atr and Chk1 kinases (Sancar et al., 2004) and these kinases are not involved in deregulated E2F1 signaling (Rogoff et al., 2004) . In rodent cells, E2F2 and E2F3a are just as effective at promoting DNA replication as E2F1, indicating that some aspect of replication fork dynamics activated by E2F1 expression would have to be different from the forks activated by E2F2 or E2F3a expression. In addition, the percentage of cells positive for gH2AX foci was not substantially different in serum-starved or cycling cells expressing E2F1 or E7 (data not shown), suggesting that S-phase entry is not needed for E2F1-associated DSBs to occur.
Based on our observations, we suggest that the ability to signal apoptosis by E2F1, or c-Myc for that matter, may have more to do with DSB accumulation than with the ability to promote S-phase progression. Additionally, it appears that E2F1 overexpression in NHFs may Figure 5 Deregulated E2F1-induced DSB accumulation occurs independent of Atm, p53, and caspase activation. (a, b) AT or NDF cells were infected with AdE2F1, AdE7, or AdCon, and fixed and stained for gH2AX foci formation 24 hpi (a) or subjected to neutral comet assay (b). (c) Western blot analysis for p53 (top). Lysates were generated from NHFs that were transfected with sip53A, sip53B, or siCon 48 h post transfection. Apoptosis analysis is shown (bottom) for transfected cells that were also infected with AdE2F1 or AdCon 24 h post transfection. Apoptosis assay was performed 72 hpi. (d, e) Cells were transfected and infected as in (c). At 24 hpi, cells were fixed and immunostained for gH2AX foci formation (d) or subjected to neutral comet assay (e). (f) Western blot analysis for cleaved caspase 3 (top). NHFs were transfected with siRbA or siCon and immediately following transfection, treated with zVAD-fmk or a DMSO control. Lysates were generated 72 h post transfection. Quantitation of gH2AX-positive cells (bottom). At 48 h post transfection and with zVAD-fmk treatment, cells were fixed, immunostained, and scored for gH2AX foci formation.
actually signal a G1 checkpoint that involves the NBS1, 53BP1, p53, and p21 proteins, protects against apoptosis, and does not require the DNA binding activity or transcriptional activation domain of E2F1 (Frame et al., submitted; Lomazzi et al., 2002) . Therefore, it appears that in human cells, the initial response to E2F1-associated DSBs is to signal a checkpoint, but if the DSBs persist, apoptosis eventually predominates. It is interesting to note that a cell cycle checkpoint does not seem to occur in rodent cells despite the localization of gH2AX in response to Rb excision in Rb conditional mouse adult fibroblasts (Bosco, 2004) ; rather rodent cells enter S phase and undergo apoptosis (Johnson et al., 1993; Kowalik et al., 1995; DeGregori et al., 1997) .
These observations may also explain why p53 mutations are so critical to tumor formation with cells lacking functional Rb. In order for a cell to survive the continuous assault of DSBs associated with Rb inactivation and E2F1 deregulation, it may be necessary for cells to inactivate p53 to bypass DNA damage checkpoint signaling and subsequent apoptosis. If correct, then these results also shed light on why Rb inactivation is associated with p53 mutations in cancer cells, like SaOS2 cells, and why this correlation is not always observed in cancer cells that have mutations in the Rb pathway but retain functional pRb, like U2OS cells.
In summary, we have shown that Rb inactivation and resultant E2F1 deregulation result in DSB accumulation in normal and transformed human cells. These DSBs may supply potential tumor cells with mutagenic opportunities that facilitate cancer progression and provide established cancer cells with continuous opportunities for subsequent mutations to occur.
Materials and methods
Cell culture and drug treatment Diploid human embryonic lung fibroblasts (GM01604; NHF) were obtained from ATCC. Normal human dermal fibroblasts (GM00316B; NDF) and AT dermal fibroblasts (GM05823C; AT) were purchased from Coriell Cell Repositories. The human osteosarcoma cell lines, SaOS2 and U2OS, were a gift from Steve Grossman (University of Massachusetts Medical School, Worcester, MA, USA). Cells were maintained in DMEM (Gibco) supplemented with 10% fetal bovine serum and 1% penicillin-streptomycin.
Hydrogen peroxide (H 2 O 2 ), etoposide, and the ROS inhibitor NAC were purchased from Sigma. The caspase inhibitor zVAD-fmk was purchased from Alexis Biochemical. The drugs were added to the media immediately following infection or transfection.
Adenoviral vectors
Recombinant adenoviruses encoding E2F1, E2F3a, AdMyc, and E7 have been described previously (Kowalik et al., 1995; Schwarz et al., 1995; DeGregori et al., 1997; Sears et al., 2000) . AdCon refers to control viruses that encode either an empty expression cassette or b-galactosidase (Rogoff et al., 2004) and had no effect on parameters tested relative to mock infection (data not shown). Virus propagation, purification, titering, and infections were performed as described (Rogoff et al., 2004) . The MOI was 1000 in dermal fibroblasts and 500 in NHFs unless otherwise noted.
RNA interference
NHFs were transfected using Lipofectamine 2000 and the SaOS2 and U2OS cells were transfected using Oligofectamine as described by the manufacturer (Invitrogen). The siRNA oligonucleotides were transfected at 60 nM for 4 h. Control siRNAs (siCon) recognize GFP, retrovirus LTR, or a nonsense sequence had no effect on parameters tested relative to mock transfection. The sequences of the siRNAs directed against E2F1, E2F3a, GFP and LTR are described by Rogoff et al. (2004) ; the sequences for all other siRNAs are as follows:
gH2AX immunofluorescence Cells were transfected as needed and after 24 h, were plated onto treated coverslips at 4000 cells/cm 2 . Cells were infected 12 h after plating and fixed for immunostaining 24 h later by washing with PBS and treating with 3.7% formaldehyde/PBS for 10 min at room temperature (RT). Cells were then washed with PBS and À201C methanol was added for 30 min. Cells were washed with PBS, blocked in 3% BSA/PBS for 1 h at RT, and incubated with gH2AX monoclonal antibody (Upstate Biotechnology) for 1.5 h at RT. Bound antibody was detected using rhodamine red-X conjugated secondary antibody (Jackson Immunoresearch Laboratories Inc.). Coverslips were mounted onto slides using Hard Set Vectashield with DAPI (Vector Laboratories Inc.).
To quantitate the percentage of cells that were positive for gH2AX foci, at least 200 cells per treatment were counted and considered positive if they had three or more foci per cell. To determine the average number of foci per cell, at least 50 nuclei of randomly chosen gH2AX-positive cells were focused with a Â 100 objective, the number of foci was counted, and the average number of foci per nucleus was calculated. Error bars represent the standard deviation of experiments carried out in triplicate.
Neutral comet assay Cells were transfected as needed and plated at 1 Â 10 5 cells/well of a six-well plate. Cells were infected with recombinant adenovirus 12 h after plating. Experiments using siRb were harvested 48 h post transfection and all other experiments were harvested at 24 hpi. As positive controls, cells were treated either with 30 mM etoposide for 45 min or 1 mM H 2 O 2 for 20 min prior to harvesting. Cells were processed for comet tail formation using neutral comet assay conditions according to the manufacturer's instructions (Trevigen).
Comets were analysed using the measurement tool in OpenLab software. The lengths of the comet head and tail were recorded for at least 50 comets on two separate slides (total cell number >100) per treatment. The ratio of tail length to head length was calculated and cells with a ratio greater than or equal to 2 were counted positive for DSBs. Figures show the percentage of cells positive for DSBs per treatment and the standard deviation for experiments carried out in triplicate.
Immunoblot analysis Whole-cell extracts were harvested from cells at 24 hpi or 48 h post transfection. Cell lysate generation and immunoblots were performed as previously described (Rogoff et al., 2004) . E2F1 and E2F3a were detected using the polyclonal antisera C-20 and C-18, respectively (Santa Cruz Biotechnology). p53 and pRb were detected using monoclonal antibodies D0-1 and AF11, respectively (Calbiochem). Actin levels, detected using polyclonal antisera I-19 (Santa Cruz Biotechnology), are included as protein loading controls. Immunoreactive proteins were detected by chemiluminescence (Perkin-Elmer).
Apoptosis analysis by ELISA Cells were transfected with siRNAs as described above. After 24 h, transfected cells were plated into 12-well plates at 2 Â 10 4 cells/well and viral infections were performed 12 h after replating. Cells were harvested at 72 hpi and analysed according to the Cell Death Detection ELISA plus protocol as described (Rogoff et al., 2004) . The ordinate axis represents the extent of apoptosis relative to control, which is defined as 1. Error bars represent the standard deviations calculated from an experiment performed in triplicate.
